Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. (EGX:RMDA)

Market Cap	6.56B
Revenue (ttm)	2.77B
Net Income (ttm)	363.84M
Shares Out	1.50B
EPS (ttm)	0.24
PE Ratio	18.03
Forward PE	12.13
Dividend	0.07 (1.54%)
Ex-Dividend Date	n/a

Volume	8,781,490
Average Volume	8,611,625
Open	4.280
Previous Close	4.280
Day's Range	4.280 - 4.400
52-Week Range	1.850 - 4.700
Beta	0.23
RSI	49.02
Earnings Date	Apr 1, 2025

About EGX:RMDA

Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E., together with its subsidiaries, produces and sells a range of branded generic pharmaceuticals, food supplements, veterinary products, and nutraceuticals in Egypt. The company manufactures, markets, sells, and stores pharmaceutical reagents for human and veterinary use, and diagnostic reagents for individuals, laboratories, and hospitals; imports pharmaceutical reagents and raw materials; and produces food supplements for human use. It offers a portfolio of p...

• Industry: Pharmaceutical Preparations
• Founded: 1986
• Country: Egypt
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: RMDA

Financial Performance

In 2024, EGX:RMDA's revenue was 2.77 billion, an increase of 44.03% compared to the previous year's 1.92 billion. Earnings were 363.84 million, an increase of 62.79%.